Selected article for: "common one and lymphocyte count"
Author: Turan, Onur; Arpınar Yigitbas, Burcu; Turan, Pakize Ayşe; Mirici, Arzu
Title: Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD
  • Cord-id: tbesmu7f
  • Document date: 2021_5_13
    • ID: tbesmu7f
    Snippet: BACKGROUND: Although COPD is not one of the most common comorbidities in COVID-19 patients, it can be more fatal in this group. This study aimed to investigate the characteristics and prognosis of COPD patients among the population with COVID-19. RESEARCH DESIGN AND METHODS: Patients diagnosed with positive PCR test were included in our multicentered, retrospective study. Patients with airway obstruction (previous spirometry) were included in ‘COPD group’. RESULTS: The prevalence of COPD in
    Document: BACKGROUND: Although COPD is not one of the most common comorbidities in COVID-19 patients, it can be more fatal in this group. This study aimed to investigate the characteristics and prognosis of COPD patients among the population with COVID-19. RESEARCH DESIGN AND METHODS: Patients diagnosed with positive PCR test were included in our multicentered, retrospective study. Patients with airway obstruction (previous spirometry) were included in ‘COPD group’. RESULTS: The prevalence of COPD in COVID-19 patients was 4.96%(53/1069). There was a significant difference between COPD and non-COPD COVID-19 patients in terms of gender, mean age, presence of dyspnea, tachypnea, tachycardia, hypoxemia and presence of pneumonia. The mortality rate was 13.2% in COPD, 7% in non-COPD patients(p = 0.092). The significant predictors of mortality were higher age, lymphopenia (p < 0.001), hypoxemia (p = 0.028), high D-dimer level (p = 0.011), and presence of pneumonia (p = 0.043) in COVID-19 patients. CONCLUSIONS: Our research is one of the first studies investigating characteristics of COPD patients with COVID-19 in Turkey. Although COPD patients had some poor prognostic features, there was no statistical difference between overall survival rates of two groups. Age, status of oxygenization, serum D-dimer level, lymphocyte count and pneumonia were significantly associated parameters with mortality in COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute hypoxemic respiratory failure and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute hypoxemic respiratory failure and lung function: 1, 2
    • acute hypoxemic respiratory failure and lung tissue: 1, 2, 3
    • admission lymphopenia and low lymphocyte count: 1
    • admission lymphopenia and lung disease: 1, 2, 3, 4
    • admission lymphopenia and lung function: 1, 2
    • admission lymphopenia and lung involvement: 1
    • admission time and low lymphocyte count: 1, 2, 3, 4, 5, 6
    • admission time and lung capacity: 1
    • admission time and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • admission time and lung function: 1, 2, 3
    • admission time and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • admission time and lung tissue: 1
    • low absolute and lung disease: 1
    • low absolute and lung function: 1
    • low absolute and lung involvement: 1, 2
    • low absolute lymphocyte count and lung involvement: 1
    • low lymphocyte count and lung involvement: 1, 2